New immune weapon tested against advanced prostate cancer

NCT ID NCT05818683

Recruiting now Disease control Sponsor: Janssen Research & Development, LLC Source: ClinicalTrials.gov ↗

Summary

This early-stage study is testing a new drug, JNJ-78278343, that aims to guide the body's own immune cells to attack prostate cancer. It is being given in combination with other standard treatments like immunotherapy, chemotherapy, or hormone therapy. The main goals are to find a safe and effective dose and to see if the treatment causes tumors to shrink in men whose cancer has spread.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC HORMONE SENSITIVE PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Florida Cancer Specialists
RECRUITING

Sarasota, Florida, 34232, United States
Hosp Univ Fund Jimenez Diaz
RECRUITING

Madrid, 28040, Spain
Hosp Univ Hm Sanchinarro
RECRUITING

Madrid, 28050, Spain
Hosp Univ Vall D Hebron
RECRUITING

Barcelona, 8035, Spain
Hosp. Univ. 12 de Octubre
RECRUITING

Madrid, 28041, Spain
Icon Cancer Centre Kurralta Park
RECRUITING

Kurralta Park, 5037, Australia
Laura & Isaac Perlmutter Cancer Center at NYU Langone Hospital - Long Island
RECRUITING

Mineola, New York, 11501, United States
Macquarie University
RECRUITING

Macquarie University, 2109, Australia
NYU Langone Health
RECRUITING

New York, New York, 10016, United States
Perlmutter Cancer Center at NYU Langone Brooklyn
RECRUITING

Brooklyn, New York, 11223, United States
Peter MacCallum Cancer Centre
RECRUITING

Melbourne, 3000, Australia
Princess Alexandra Hospital
RECRUITING

Woolloongabba, 4102, Australia
Sidney Kimmel Cancer Center - Jefferson Health
RECRUITING

Philadelphia, Pennsylvania, 19107, United States
Start Midwest
RECRUITING

Grand Rapids, Michigan, 49546, United States
Washington University School Of Medicine
RECRUITING

St Louis, Missouri, 63110, United States

Conditions

Explore the condition pages connected to this study.

METASTATIC CASTRATION-RESISTANT PROSTATE NEOPLASMS METASTATIC HORMONE SENSITIVE PROSTATE CANCER